Is that right? I thought it just permits a full dosage for those whose GI doesn't tolerate the active ingredient. I have not understood that it extends signficantly the period over which the ingredient is absorbed. As of a year or so ago (probably longer), it was not in United Health's formulary of reimbursable prescription pharmaceuticals, which seemed peculiar to me. Extended release would seem compelling.